Stock Market

ADMA Biologics stock surges 11.6% after denying short seller claims

By Bullbit Editorial · March 28, 2026

WhatADMA Biologics stock price jumped 11.6% after the company denied allegations made by short sellers.
WhyThe firm's denial is seen as a positive development for investors, potentially boosting ADMA's stock value.
SignalThis significant price increase may signal a shift in investor sentiment towards ADMA, driven by the company's response to short seller claims.
TargetADMA's stock may be targeting a new resistance level, potentially reaching **$10.50** in the near future.
RiskHowever, the risk of a short squeeze remains, and investors should closely monitor ADMA's stock performance for any potential volatility.